Baseline Study Sample Clauses

Baseline Study. The Recipient shall carry out a baseline study of the Project’s outcome indicators agreed with the Association, including an assessment of the socio-economic status of the target populations using said indicators, and shall prepare and furnish to the Association, not later than twelve (12) months after the Effective Date, a report integrating the results of said baseline study.
Sample 1Sample 2
AutoNDA by SimpleDocs
Baseline Study. Xxxxx and Xxxx hereby agree that a Pre- Acquisition Review assessment report of the Property by Xxxxx, if made, shall establish the true and correct condition of the Property as of the Effective Date and such assessment report shall be used as the only environmental, safety or other baseline study in the event a dispute arises after Closing concerning the condition of the Property, unless Aera gives notice to Xxxxx within thirty (30) days after its receipt of the Pre-Acquisition Review assessment report that it is contesting the results of or the conclusions reached in such assessment report in which case such Pre-Acquisition Review assessment report shall not be deemed the sole baseline study. Aera shall have the right, but not the obligation, at any time to conduct its own assessment of the Property. If prior to Closing, Aera determines, either from its own assessment, Xxxxx'x assessment or otherwise, that an adverse environmental condition may exist on any portion of the Property, then Aera may, in its sole discretion, either (i) remove the affected portion of the Property from the Property being conveyed and agree with Xxxxx to an adjusted Purchase Price or (ii) terminate this Agreement by giving notice of such termination to Xxxxx in writing prior to Closing. The rights and obligations of the Parties after such notice is given shall be as specified in the next sentence. If Aera and Xxxxx cannot agree on the proper adjustment to the Purchase Price, either Party may give written notice to the other Party prior to Closing to terminate this Agreement and upon the giving of such notice, neither Party shall have any further rights or obligations hereunder except for Xxxxx'x obligations and Xxxx's rights under the Confidentiality Agreement and the Indemnification Agreement. In the event both Aera and Xxxxx elect not to conduct Pre-Acquisition Review assessment reports, both Parties agree that the Phase I Environmental Site Assessment report dated October 27, 1998, prepared by Xxxxxxx/Xxxxx Consultants for Mobil Business Resources Corporation shall serve as the baseline study for purposes of this subsection.
Sample 1
Baseline Study. During this phase, a baseline study will be conducted. The consultant will be expected to actively participate in this baseline study. Risk analysis: Risks analysis will be conducted by the consultant. Identify risk covering contextual, but also operational and reputation risks. Each risk should be measured by estimating its probability and impact. Develop mitigation measures and actions for each of the risks. Please note that the formulation of the global partnership opportunities will follow a similar methodology taking into the specific requirements of the third-party donor.
Sample 1
Baseline Study. 1.1 A baseline study shall be conducted: (a) to compile an inventory of archaeological sites (including marine archaeological sites where applicable), historic buildings and structures within the proposed development areas, which include: (i) all sites of archaeological interest (including marine archaeological sites where applicable); (ii) all pre-1950 buildings and structures; (iii) selected post-1950 buildings and structures of high architectural and historical significance and interest; and (iv) cultural landscape and features including sites of historical events or providing a significant historical record or a setting for buildings or monuments of architectural or archaeological importance, historic field patterns, tracks and fish ponds and cultural elements such as xxxx xxxx woodlands and clan grave; (b) to identify the impacts of the proposed developments on the site of cultural heritage at the planning stage in order to avoid causing any negative effects.
Sample 1
Baseline Study. A desk-based study was undertaken and a review of previous investigation reports was also included to locate previously identified resources and also to update previous impact assessments and mitigation recommendations.
Sample 1
Baseline Study. Buyer and Noble hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "PRE-ACQUISITION ENVIRONMENTAL ASSESSMENT") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Noble shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1
Baseline Study. TechnoServe will initiate the baseline study once USDA has approved the Evaluation Plan. TechnoServe hopes to be able to schedule the baseline study to be undertaken between November 15 and January 31st, 2015 by an external and specialized evaluation firm. TechnoServe will select the firm on a competitive basis, and will ensure that the selected firm complies with the following requirements:  Is financially and legally separate from the participant's organization;  Has staff with demonstrated knowledge, analytical capability, language skills and experience in conducting evaluations of development programs in African agriculture and agribusiness;  Uses acceptable analytical frameworks and methods to assess results, involving stakeholders and applying statistical analyses;  Uses local consultants, as appropriate, to conduct data collection and portions of the baseline studies; and,  Provides a detailed plan for the baseline study, major tasks and specific schedules prior to initiating the studies. TechnoServe will ensure that the evaluating firm has complete access to all relevant internal and external project documents, key correspondence with OCBD staff, and any other relevant project information that may facilitate the transparent and robust execution of the baseline study. The baseline study will help TechnoServe and OCBD staff optimize the initial allocation of project funding to achieve CIAP results and will be consistent with the following ROM criteria: Independence, Utility, Transparency, Relevance, Partnerships, Credibility, Rigor and Timeliness. The purpose of the baseline study is to:  Establish benchmarks against which CIAP’s progress on each of the project outcomes can be tracked, and  Inform decision-making about early project implementation planning and execution. 1The number of surveys will be sufficient to achieve a 95% confidence level as determined by the variance discovered during quantitative surveys during the baseline assessment. The variance of population determines the number of surveys required in order to achieve statistical significance.  Refine metrics: TechnoServe will coordinate with CIAP and M&E staff to finalize the proposed revised indicators and targets, with a set of compelling, defensible and credible metrics that are practical and relevant in indicating progress toward key outcomes. A final PMP will be submitted to USDA within 90 days of award, and all indicators and indicator targets will be finalized by Month 5...
Sample 1
AutoNDA by SimpleDocs
Baseline Study. Buyer and Aera hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "PRE-ACQUISITION ENVIRONMENTAL ASSESSMENT") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Aera shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1
Baseline Study. Buyer and Shell hereby agree that, prior to the Execution Date, Buyer was offered an opportunity to conduct a pre-acquisition review environmental assessment report (the "Pre-Acquisition Environmental Assessment") of the Property. Buyer elected to not conduct a Pre-Acquisition Environmental Assessment. Shell shall have the right, but not the obligation, at any time (before or after the Closing) to conduct its own assessments of the Property.
Sample 1

Related to Baseline Study

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Feasibility Study A feasibility study will identify the potential costs, service quality and other benefits which would result from contracting out the work in question. The cost analysis for the feasibility study shall not include the Employer’s indirect overhead costs for existing salaries or wages and benefits for administrative staff or for rent, equipment, utilities, and materials, except to the extent that such costs are attributable solely to performing the services to be contracted out. Upon completion of the feasibility study, the Employer agrees to furnish the Union with a copy if the feasibility study, the bid from the Apparent Successful Bidder and all pertinent information upon which the Employer based its decision to contract out the work including, but not limited to, the total cost savings the Employer anticipates. The Employer shall not go forward with contracting out the work in question if more than sixty percent (60%) of any projected savings resulting from the contracting out are attributable to lower employee wage and benefit costs.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!